Concerns about statins and dementia trace back to the early 2000s, when some patients reported cognitive issues like short-term memory loss after starting statin therapy or increasing their dosage. In many cases, these symptoms improved once the medication was stopped and reappeared when restarted, suggesting a reversible effect rather than progressive dementia like Alzheimer’s. Statins such as simvastatin, atorvastatin, and pravastatin were mentioned most often in these reports.
The initial worry stemmed from the fact that statins lower cholesterol and can cross into the brain, raising questions about whether they might interfere with cognitive function for some people. Early clinical trials also recorded rare instances of mental confusion or restlessness at high doses. However, these cognitive effects were considered uncommon and typically temporary.
Most findings show that statins do not increase dementia risk and may even offer protective benefits for the brain by improving cardiovascular health. Better blood flow and reduced inflammation from statins can indirectly support brain health, potentially lowering dementia risk over time.
In short, while early case reports raised concerns about temporary cognitive effects in some individuals, extensive research has shown that statins are generally safe regarding dementia risk. In fact, they might offer long-term benefits for brain health in addition to their cardiovascular advantages.